Loading stock data…
$31.67+1.44 (+4.76%)
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. in the Healthcare sector is trading at $31.67 with a market capitalization of $2.6B. Wall Street consensus targets $33.79 (14 analysts), implying a +6.7% move over the next 12 months. The stock is currently near its 52-week high of $35.83, remaining 27.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $865.84M↑ | $828.80M↑ | $821.46M↓ | $851.57M↓ | $869.23M |
| Gross Profit | $835.64M↑ | $799.31M↑ | $790.70M↓ | $821.16M↓ | $840.70M |
| Operating Income | $87.77M↑ | $83.84M↑ | $47.64M↓ | $119.52M↓ | $142.30M |
| Net Income | $10.93M↑ | $4.11M↑ | -$1.18B↓ | $36.25M↑ | $30.13M |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...